These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 14668036

  • 1. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P, Sica S, Leone G.
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY, Kao A, Yen RF.
    Oncol Rep; 2002 Dec; 9(2):321-5. PubMed ID: 11836600
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
    Spaepen K, Mortelmans L.
    Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
    [Abstract] [Full Text] [Related]

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M.
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [Abstract] [Full Text] [Related]

  • 5. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.
    Cancer; 2002 Feb 15; 94(4):879-88. PubMed ID: 11920454
    [Abstract] [Full Text] [Related]

  • 6. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.
    Montravers F, McNamara D, Landman-Parker J, Grahek D, Kerrou K, Younsi N, Wioland M, Leverger G, Talbot JN.
    Eur J Nucl Med Mol Imaging; 2002 Sep 15; 29(9):1155-65. PubMed ID: 12192560
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.
    Cremerius U, Fabry U, Neuerburg J, Zimny M, Bares R, Osieka R, Büll U.
    Nuklearmedizin; 2001 Feb 15; 40(1):23-30. PubMed ID: 11373935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U.
    Radiol Clin North Am; 2007 Jul 15; 45(4):697-709, vii. PubMed ID: 17706534
    [Abstract] [Full Text] [Related]

  • 10. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
    Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, Vitolo U, Mancini M, Bisi G, Gallo E.
    Radiol Med; 2008 Jun 15; 113(4):578-90. PubMed ID: 18414808
    [Abstract] [Full Text] [Related]

  • 11. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G.
    Q J Nucl Med Mol Imaging; 2008 Mar 15; 52(1):9-16. PubMed ID: 18235420
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S.
    Eur J Nucl Med Mol Imaging; 2005 Jul 15; 32(7):749-56. PubMed ID: 15785956
    [Abstract] [Full Text] [Related]

  • 13. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
    Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Pötzi C, Raderer M, Dudczak R, Kletter K.
    Leukemia; 2002 Feb 15; 16(2):260-7. PubMed ID: 11840293
    [Abstract] [Full Text] [Related]

  • 14. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
    Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME.
    J Nucl Med; 1997 Mar 15; 38(3):343-8. PubMed ID: 9074514
    [Abstract] [Full Text] [Related]

  • 15. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L, Chen Y, Wu J.
    Hell J Nucl Med; 2013 Mar 15; 16(3):230-6. PubMed ID: 24137577
    [Abstract] [Full Text] [Related]

  • 16. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
    Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS.
    Oncologist; 2009 Mar 15; 14 Suppl 2():30-40. PubMed ID: 19819922
    [Abstract] [Full Text] [Related]

  • 17. (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging.
    Lopci E, Burnelli R, Ambrosini V, Nanni C, Castellucci P, Biassoni L, Rubello D, Fanti S.
    Cancer Biother Radiopharm; 2008 Dec 15; 23(6):681-90. PubMed ID: 19111053
    [Abstract] [Full Text] [Related]

  • 18. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L.
    Semin Radiat Oncol; 2007 Jul 15; 17(3):190-7. PubMed ID: 17591566
    [Abstract] [Full Text] [Related]

  • 19. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J.
    Radiol Clin North Am; 2007 Jan 15; 45(1):69-83. PubMed ID: 17157624
    [Abstract] [Full Text] [Related]

  • 20. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET.
    Altamirano J, Esparza JR, de la Garza Salazar J, Calvo PS, Vera SR, Chalapud Revelo JR, Estrada G.
    Arch Med Res; 2008 Jan 15; 39(1):69-77. PubMed ID: 18067998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.